
zzso is a targeted therapy that zzso zzso target of zzso zzso a central regulator of tumor cell responses to growth zzso zzso has a broad zzso activity profile that impacts tumor cell growth, zzso and survival through its specific zzso of zzso In a zzso phase III trial that enrolled previously zzso patients with advanced zzso cell zzso zzso and poor zzso features, zzso significantly prolonged overall survival compared with zzso a standard therapy zzso zzso zzso Because of the results, zzso was approved by the zzso zzso Food and Drug Administration for treatment and is considered a zzso treatment for patients with advanced zzso with poor zzso zzso zzso is administered at a flat weekly IV dose of 25 zzso given over zzso zzso zzso disorders zzso zzso zzso zzso and zzso zzso fatigue, zzso infections, and zzso as well as zzso and zzso laboratory abnormalities occur in patients receiving zzso zzso side effects include zzso zzso zzso and zzso Most adverse reactions associated with zzso can be managed medically or addressed by supportive zzso Nurses can improve patient outcomes through early recognition of side effects and prompt zzso 

